Manher AJ Joshi
Nessuna posizione attualmente
Patrimonio netto: 133 259 $ in data 29/02/2024
Profilo
Manher AJ Joshi is former Chief Medical Officer & Executive Vice President at Atara Biotherapeutics, Inc., former Head-US Medical Affairs at Allergan, Inc., former Vice President-Medical Affairs & Operations at Genzyme Corp.
and former SVP-Strategic Development & Medical Operations at Synageva BioPharma Corp.
Dr. Joshi received a doctorate from Boston University School of Medicine and an undergraduate degree from Boston University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
16/11/2023 | 171 284 ( 0.13% ) | 133 259 $ | 29/02/2024 |
Precedenti posizioni note di Manher AJ Joshi
Società | Posizione | Fine |
---|---|---|
ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/02/2024 |
SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01/07/2010 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2008 |
ALLERGAN, INC. | Corporate Officer/Principal | - |
Formazione di Manher AJ Joshi
Boston University | Undergraduate Degree |
Boston University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |